A clinical-economic study of caspofungin use in the treatment of invasive candidiasis in intensive care units
Candida spp. are the fourth on the list of sepsis pathogens in patients in intensive care units. Currently the physician’s armamentarium includes a whole range of antifungal medicines that have demonstrated high clinicalmycological effectiveness in clinical trials. The aim of this study to evaluate...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Journal Infectology
2014-09-01
|
| Series: | Журнал инфектологии |
| Subjects: | |
| Online Access: | https://journal.niidi.ru/jofin/article/view/284 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849338428019179520 |
|---|---|
| author | A. S. Kolbin O. A. Koroleva N. N. Klimko |
| author_facet | A. S. Kolbin O. A. Koroleva N. N. Klimko |
| author_sort | A. S. Kolbin |
| collection | DOAJ |
| description | Candida spp. are the fourth on the list of sepsis pathogens in patients in intensive care units. Currently the physician’s armamentarium includes a whole range of antifungal medicines that have demonstrated high clinicalmycological effectiveness in clinical trials. The aim of this study to evaluate the clinical-economic usefulness of caspofungin therapy in the treatment of invasive candidiasis versus standard and alternative treatments in patients inintensive care units. The first time in the Russian clinical-economic analysis for targeted IC treatment in non-neutropenic patients in intensive care units who have not received primary prophylaxis with azole antimycotics, as well as in those with low (< 20%) occurrence of in vitro Candida spp. resistance to fluconazole according to national or local study results, yielded the following findings: the best strategy is initial amphotericin B therapy with subsequent switching to caspofungin in patients with ineffective initial amphotericin B therapy or those with severe adverse events. |
| format | Article |
| id | doaj-art-89bd1532cf864db5844de1b0e7767461 |
| institution | Kabale University |
| issn | 2072-6732 |
| language | Russian |
| publishDate | 2014-09-01 |
| publisher | Journal Infectology |
| record_format | Article |
| series | Журнал инфектологии |
| spelling | doaj-art-89bd1532cf864db5844de1b0e77674612025-08-20T03:44:24ZrusJournal InfectologyЖурнал инфектологии2072-67322014-09-0121425010.22625/2072-6732-2010-2-1-42-50298A clinical-economic study of caspofungin use in the treatment of invasive candidiasis in intensive care unitsA. S. Kolbin0O. A. Koroleva1N. N. Klimko2Saint-Petersburg state university, Saint-PetersburgSaint-Petersburg state university, Saint-PetersburgSaint-Petersburg Medical Academy of Postgraduate Education, Saint-PetersburgCandida spp. are the fourth on the list of sepsis pathogens in patients in intensive care units. Currently the physician’s armamentarium includes a whole range of antifungal medicines that have demonstrated high clinicalmycological effectiveness in clinical trials. The aim of this study to evaluate the clinical-economic usefulness of caspofungin therapy in the treatment of invasive candidiasis versus standard and alternative treatments in patients inintensive care units. The first time in the Russian clinical-economic analysis for targeted IC treatment in non-neutropenic patients in intensive care units who have not received primary prophylaxis with azole antimycotics, as well as in those with low (< 20%) occurrence of in vitro Candida spp. resistance to fluconazole according to national or local study results, yielded the following findings: the best strategy is initial amphotericin B therapy with subsequent switching to caspofungin in patients with ineffective initial amphotericin B therapy or those with severe adverse events.https://journal.niidi.ru/jofin/article/view/284candidiasisintensive care unitsclinicaleconomic analysis |
| spellingShingle | A. S. Kolbin O. A. Koroleva N. N. Klimko A clinical-economic study of caspofungin use in the treatment of invasive candidiasis in intensive care units Журнал инфектологии candidiasis intensive care units clinicaleconomic analysis |
| title | A clinical-economic study of caspofungin use in the treatment of invasive candidiasis in intensive care units |
| title_full | A clinical-economic study of caspofungin use in the treatment of invasive candidiasis in intensive care units |
| title_fullStr | A clinical-economic study of caspofungin use in the treatment of invasive candidiasis in intensive care units |
| title_full_unstemmed | A clinical-economic study of caspofungin use in the treatment of invasive candidiasis in intensive care units |
| title_short | A clinical-economic study of caspofungin use in the treatment of invasive candidiasis in intensive care units |
| title_sort | clinical economic study of caspofungin use in the treatment of invasive candidiasis in intensive care units |
| topic | candidiasis intensive care units clinicaleconomic analysis |
| url | https://journal.niidi.ru/jofin/article/view/284 |
| work_keys_str_mv | AT askolbin aclinicaleconomicstudyofcaspofunginuseinthetreatmentofinvasivecandidiasisinintensivecareunits AT oakoroleva aclinicaleconomicstudyofcaspofunginuseinthetreatmentofinvasivecandidiasisinintensivecareunits AT nnklimko aclinicaleconomicstudyofcaspofunginuseinthetreatmentofinvasivecandidiasisinintensivecareunits AT askolbin clinicaleconomicstudyofcaspofunginuseinthetreatmentofinvasivecandidiasisinintensivecareunits AT oakoroleva clinicaleconomicstudyofcaspofunginuseinthetreatmentofinvasivecandidiasisinintensivecareunits AT nnklimko clinicaleconomicstudyofcaspofunginuseinthetreatmentofinvasivecandidiasisinintensivecareunits |